Peptonic Medical AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 37
- Market Cap
- -
Clinical Trials
8
Active:1
Completed:6
Trial Phases
3 Phases
Phase 1:1
Phase 2:5
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (62.5%)Not Applicable
2 (25.0%)Phase 1
1 (12.5%)Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis
Not Applicable
- Conditions
- Candidal VulvovaginitisVulvovaginal CandidiasisVaginal Candidiasis
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- PepTonic Medical AB
- Target Recruit Count
- 126
- Registration Number
- NCT05012852
- Locations
- 🇸🇪
Karolinska University Hospital, Huddinge, Sweden
Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms
Phase 2
Completed
- Conditions
- Vulvovaginal Atrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- PepTonic Medical AB
- Target Recruit Count
- 202
- Registration Number
- NCT04629885
- Locations
- 🇸🇪
Kvinnoforskningsenheten K59, Karolinska Universitetssjukhuset, Huddinge, Sweden
🇸🇪Kvinnokliniken, Norrlands Universitetssjukhus, Umeå, Sweden
🇸🇪Kvinnokliniken, Akademiska sjukhuset, Uppsala, Sweden
Evaluation of VagiVital® for Treatment of Vaginal Atrophy
Not Applicable
Completed
- Conditions
- Vaginal Atrophy
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- PepTonic Medical AB
- Target Recruit Count
- 31
- Registration Number
- NCT03998722
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Sweden
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- PepTonic Medical AB
- Target Recruit Count
- 227
- Registration Number
- NCT02497547
- Locations
- 🇸🇪
Hoftekliniken, Helsingborg, Sweden
🇸🇪Qvinnolivet Specialistläkarna Kungsbacka, Kungsbacka, Sweden
🇸🇪Kvinnoforskningsenheten, Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden
Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women
Phase 2
Completed
- Conditions
- Vaginal Atrophy
- Interventions
- First Posted Date
- 2013-11-19
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- PepTonic Medical AB
- Target Recruit Count
- 64
- Registration Number
- NCT01987804
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Huddinge, Sweden
- Prev
- 1
- 2
- Next
News
No news found